Citation

The Medical Letter on Drugs and Therapeutics 2020; 62(1607): e151.

Copyright

(Copyright © 2020)

DOI

unavailable

PMID

32960869

Abstract

[Abstract unavailable]

Language: en

Keywords

adverse effects; antidepressants; Antidepressive Agents; depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; dosage; efficacy; esketamine; Humans; Ketalar; Ketamine; lactation; Nasal Sprays; pregnancy; safety; Spravato; Suicidal Ideation